Request Demo
Recent blog posts
Latest Hotspot
8 min read
APOBR Biologics Sequence Review Report 2026: Apolipoprotein B receptor Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of APOBR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
APELA Biologics Sequence Review Report 2026: Apelin receptor early endogenous ligand Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of APELA sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRL3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRL3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRG6 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G6 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRG6 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRG2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRG2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRF3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor F3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRF3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRF1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor F1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRF1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRD2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor D2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRD2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRA3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor A3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRA3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRA2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor A2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADGRA2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADAMTS7 Biologics Sequence Review Report 2026: A disintegrin and metalloproteinase with thrombospondin motifs 7 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADAMTS7 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADAMTS12 Biologics Sequence Review Report 2026: A disintegrin and metalloproteinase with thrombospondin motifs 12 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of ADAMTS12 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.